Can telehealth stop HIV in its tracks? new trial tests two strategies
NCT ID NCT05897099
First seen Feb 23, 2026 · Last updated May 04, 2026 · Updated 8 times
Summary
This study compares two methods of offering HIV prevention medication, hepatitis C treatment, and substance use disorder treatment via telehealth to 350 people who inject drugs. Participants must be HIV-negative and have exchanged syringes recently. The goal is to see which approach works better at preventing HIV and improving overall health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IDEA Miami
RECRUITINGMiami, Florida, 33136, United States
-
IDEA Syringe Services Program
NOT_YET_RECRUITINGMiami, Florida, 33136, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.